Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib + methotrexate for ectopic pregnancy II
2011-001747-69Phase 4Completed
- Sponsor
- Monash University
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gefitinib and methotrexate in Ectopic pregnancy (EP) and Pregnancy of unknown location (PUL) (2 arms), sponsored by Monash University. Primary endpoint: Successful resolution of ectopic pregnancy. Started Sep 2011; status: completed.
02
Drugs
gefitinibmethotrexate
03
Conditions
Ectopic pregnancy (EP)Pregnancy of unknown location (PUL)
Beyond the preview
Go deeper on 2011-001747-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001747-69.